Archives
-
LMO2–LDB1 Control of AML: Evidence and Methods
2026-10-01
The reference study identifies an LMO2–LDB1 protein complex as a functional regulator of acute myeloid leukemia cell proliferation and survival. By combining perturbation experiments, protein-interaction analysis, in vivo validation, RNA sequencing, and ChIP-seq, it moves the field from prognostic association toward a mechanistic model of transcriptional control in AML.
-
Tioconazole Workflows for Fungal Research
2026-09-30
Build more reproducible antifungal assays with Tioconazole by controlling formulation, exposure, and ergosterol-linked readouts. This workflow also translates a recent AML study’s stress-control principles into disciplined fungal assay design without implying that the leukemia mechanism has been demonstrated in fungi.
-
GSTA1, Glutathione Depletion and α-Amanitin Toxicity
2026-09-30
A 2026 study identifies GSTA1 as an unexpected driver of α-amanitin hepatotoxicity rather than a uniformly protective detoxification enzyme. By integrating animal toxicology, multi-omics, interaction assays, and genetic silencing, the work links NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte injury.
-
FAISL–FAK Proteolysis in Triple-Negative Breast Cancer
2026-09-29
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated FAK proteolysis, thereby promoting adhesion, survival, proliferation, and metastasis in triple-negative breast cancer. Its combination of transcriptomic prioritization, RNA–protein interaction analysis, mechanistic validation, and reduction-responsive siRNA delivery provides a framework for targeting post-translational regulation of FAK.
-
Tofacitinib Citrate: From JAK3 to Vascular Insight
2026-09-29
Tofacitinib citrate (CP-690550 citrate) is more than a tool for lymphocyte proliferation inhibition. By connecting JAK-STAT signaling pathway biology with cytokine-stressed endothelial models, translational researchers can distinguish immune pathway modulation from broader vascular effects. This article interprets comparative evidence, outlines concentration-aware experimental design, and positions APExBIO product A4135 for immune regulation research and inflammatory disorder research.
-
ETS1–SENP2 Control of Mitophagy in BPD
2026-09-28
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation of FUNDC1 and HSPA8-mediated turnover. Its findings connect transcriptional control, SUMOylation, chaperone-linked degradation, and mitochondrial quality control, while providing a mechanistic framework for studying selective autophagy in developing lung tissue.
-
Ionomycin Free Acid in Calcium Signaling Workflows
2026-09-28
Use Ionomycin free acid to impose a controlled calcium perturbation alongside—not as a substitute for—the RNA and protein assays used to study FAISL–FAK biology. This practical guide covers acute calcium-flux experiments, follow-up measurements, and controls that help separate calcium-dependent responses from vehicle effects or nonspecific cell stress.
-
Syringin for RCC: Practical Assay Workflows
2026-09-27
Build a mechanism-aware renal cell carcinoma workflow with Syringin by pairing viability and apoptosis measurements with migration and EGFR/PI3K/Akt readouts. The approach also supports controlled sunitinib combination testing, while distinguishing published findings from practical pilot recommendations.
-
Meropenem Trihydrate for Resistance Research
2026-09-26
Use Meropenem trihydrate to connect antibiotic susceptibility testing with carefully controlled resistance-phenotype experiments. A recent LC-MS/MS study shows how antibiotic-free metabolite profiling can identify carbapenemase-associated signatures—and where a separate meropenem challenge arm can add mechanistic context.
-
CCCP: Practical Guide to Mitochondrial Assays
2026-09-25
Learn how CCCP (carbonyl cyanide m-chlorophenyl hydrazine), SKU B5003, can help researchers deliberately disrupt mitochondrial proton gradients while avoiding common assay-interpretation and handling pitfalls. This scenario-based guide covers mechanism, experimental design, stock preparation, data interpretation, and evidence-based product selection.
-
Viral RIPK3 Degradation Shapes Inflammation
2026-09-25
Liu and colleagues identified an orthopoxvirus protein, vIRD, that recruits host ubiquitin-ligase machinery to promote RIPK3 degradation and suppress necroptosis. Viral genetics and mouse experiments link this immune-evasion mechanism to viral replication, inflammation, and disease severity, while suggesting experiments to test the contribution of cullin neddylation.
-
WRN Loss Activates p53–PUMA in MSI Colon Cancer
2026-09-24
This study shows that p53 and its apoptotic target PUMA are required for the selective killing of mismatch repair-deficient, microsatellite-unstable colorectal cancer cells after Werner helicase loss. The findings clarify a key mechanism behind this synthetic-lethal vulnerability and suggest that p53 status matters when evaluating WRN-directed strategies.
-
Chlorpromazine HCl in Host-Directed Immunity Research
2026-09-24
Chlorpromazine HCl is a dopamine receptor antagonist with established neuropharmacology applications, but emerging phenothiazine research raises a distinct question: can host-cell responses help control intracellular bacteria? This article separates class-level findings from compound-specific evidence and turns that distinction into practical assay guidance.
-
Phillygenin Signaling in Diabetic Nephropathy
2026-09-23
A preclinical study links phillygenin treatment to reduced inflammation and apoptosis in high-glucose-exposed podocytes and db/db mice, alongside changes in TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. The findings position phillygenin as a candidate for further diabetic nephropathy research, while leaving its clinical efficacy and pathway-level causality to be established.
-
Meropenem trihydrate in Resistance Research
2026-09-23
Meropenem trihydrate supports more than routine susceptibility testing: it can anchor matched phenotyping, resistance modeling, and metabolomics workflows. This guide translates recent LC-MS/MS evidence into practical assay design, formulation, sampling, and troubleshooting choices.